These findings highlight the complex immune microenvironment in HB, with Tregs and CD8+ Tem cells playing central roles in immune evasion and tumour progression, suggesting that immune checkpoint blockade may be a promising therapeutic strategy. The gene discussed is CD8A; the disease is neoplasm.